536 related articles for article (PubMed ID: 34274177)
1. Human papillomavirus co-infection and survival in oral and oropharyngeal squamous cell carcinoma: A study in 235 Brazilian patients.
Silveira HA; Almeida LY; Carlos R; Silva EV; Ferrisse TM; Duarte A; Cardoso SCS; Polanco XBJ; Bufalino A; Ribeiro-Silva A; León JE
Auris Nasus Larynx; 2022 Apr; 49(2):258-270. PubMed ID: 34274177
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of Human Papillomavirus and Co-Infection with Epstein-Barr Virus in Oral and Oropharyngeal Squamous Cell Carcinomas.
Makvandi M; Jalilian S; Faghihloo E; Khanizadeh S; Ramezani A; Bagheri S; Mirzaei H
Asian Pac J Cancer Prev; 2022 Nov; 23(11):3931-3937. PubMed ID: 36444607
[TBL] [Abstract][Full Text] [Related]
3. Human papillomavirus and Epstein-Barr virus co-infection in oral and oropharyngeal squamous cell carcinomas: A systematic review and meta-analysis.
Rahman R; Shaikh MH; Gopinath D; Idris A; Johnson NW
Mol Oral Microbiol; 2023 Aug; 38(4):259-274. PubMed ID: 37014754
[TBL] [Abstract][Full Text] [Related]
4. A systematic investigation of the association between HPV and the clinicopathological parameters and prognosis of oral and oropharyngeal squamous cell carcinomas.
Wang F; Zhang H; Xue Y; Wen J; Zhou J; Yang X; Wei J
Cancer Med; 2017 May; 6(5):910-917. PubMed ID: 28378539
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of HPV infection in head and neck carcinomas shows geographical variability: a comparative study from Brazil and Germany.
Hauck F; Oliveira-Silva M; Dreyer JH; Perrusi VJ; Arcuri RA; Hassan R; Bonvicino CR; Barros MH; Niedobitek G
Virchows Arch; 2015 Jun; 466(6):685-93. PubMed ID: 25820374
[TBL] [Abstract][Full Text] [Related]
6. A clinical analysis of oropharyngeal squamous cell carcinoma: a single-institution's experience.
Jiromaru R; Yasumatsu R; Yamamoto H; Kuga R; Hongo T; Nakano T; Manako T; Hashimoto K; Wakasaki T; Matsuo M; Nakagawa T
Eur Arch Otorhinolaryngol; 2022 Jul; 279(7):3717-3725. PubMed ID: 34978590
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of HPV and EBV in OSCC and the expression of p53, p16, E-cadherin, COX-2, MYC, and MLH1.
de Lima MAP; Cavalcante RB; da Silva CGL; Nogueira RLM; Macedo GEC; de Galiza LE; Pinheiro JV; Maia Filho PHB; Santos SF; Rabenhorst SHB
Oral Dis; 2022 May; 28(4):1104-1122. PubMed ID: 33660890
[TBL] [Abstract][Full Text] [Related]
8. Epstein-Barr virus (EBV) and polyomaviruses are detectable in oropharyngeal cancer and EBV may have prognostic impact.
Carpén T; Syrjänen S; Jouhi L; Randen-Brady R; Haglund C; Mäkitie A; Mattila PS; Hagström J
Cancer Immunol Immunother; 2020 Aug; 69(8):1615-1626. PubMed ID: 32314041
[TBL] [Abstract][Full Text] [Related]
9. Human papillomavirus (HPV) in Chinese oropharyngeal squamous cell carcinoma (OPSCC): A strong predilection for the tonsil.
Xu T; Shen C; Wei Y; Hu C; Wang Y; Xiang J; Sun GH; Su F; Wang Q; Lu X
Cancer Med; 2020 Sep; 9(18):6556-6564. PubMed ID: 32717137
[TBL] [Abstract][Full Text] [Related]
10. Global prevalence of human papillomavirus-related oral and oropharyngeal squamous cell carcinomas: a systematic review and meta-analysis.
Fonsêca TC; Jural LA; Marañón-Vásquez GA; Magno MB; Roza ALOC; Ferreira DMTP; Maia LC; Romañach MJ; Agostini M; Abrahão AC
Clin Oral Investig; 2023 Dec; 28(1):62. PubMed ID: 38158517
[TBL] [Abstract][Full Text] [Related]
11. Oropharyngeal squamous cell carcinoma: p16/p53 immunohistochemistry as a strong predictor of HPV tumour status.
Benzerdjeb N; Tantot J; Blanchet C; Philouze P; Mekki Y; Lopez J; Devouassoux-Shisheboran M
Histopathology; 2021 Sep; 79(3):381-390. PubMed ID: 33560536
[TBL] [Abstract][Full Text] [Related]
12. HPV Status Improves Classification of Head and Neck Gray Zone Cancers.
Ren J; Xu W; Su J; Ren X; Bender N; Habbous S; de Almeida JR; Goldstein DP; Cheng D; Chen Z; Mirshams M; Rahini M; Huang SH; Spreafico A; Hansen A; Kim J; Waldron J; Perez-Ordonez B; Zhao Y; Hung R; Waterboer T; Liu G
J Dent Res; 2019 Jul; 98(8):879-887. PubMed ID: 31282843
[TBL] [Abstract][Full Text] [Related]
13. Low prevalence of p16-positive HPV-related head-neck cancers in Thailand: tertiary referral center experience.
Nopmaneepaisarn T; Tangjaturonrasme N; Rawangban W; Vinayanuwattikun C; Keelawat S; Bychkov A
BMC Cancer; 2019 Nov; 19(1):1050. PubMed ID: 31694600
[TBL] [Abstract][Full Text] [Related]
14. The utility of high-risk human papillomavirus in situ hybridization in cytology cell block material from cystic head and neck lesions.
Han LM; Saunders TA; Calkins SM
Cancer Cytopathol; 2022 Feb; 130(2):154-160. PubMed ID: 34758205
[TBL] [Abstract][Full Text] [Related]
15. HPV Infection in Squamous Cell Carcinoma of the Hypopharynx, Larynx, and Oropharynx With Multisite Involvement.
Kuga R; Yamamoto H; Jiromaru R; Hongo T; Yasumatsu R; Matsuo M; Hashimoto K; Taniguchi M; Nakagawa T; Oda Y
Am J Surg Pathol; 2023 Sep; 47(9):955-966. PubMed ID: 37357948
[TBL] [Abstract][Full Text] [Related]
16. The effect of human papillomavirus status on prognosis and local treatment strategies of T1-2N0 oropharyngeal squamous cell cancer.
Zhou P; Chen DL; Lian CL; Wu SG; Zhang SY
Front Public Health; 2022; 10():900294. PubMed ID: 35958856
[TBL] [Abstract][Full Text] [Related]
17. Impact of HPV infection on oral squamous cell carcinoma.
Götz C; Drecoll E; Straub M; Bissinger O; Wolff KD; Kolk A
Oncotarget; 2016 Nov; 7(47):76704-76712. PubMed ID: 27732948
[TBL] [Abstract][Full Text] [Related]
18. Molecular subclassification determined by human papillomavirus and epidermal growth factor receptor status is associated with the prognosis of oropharyngeal squamous cell carcinoma.
Nakano T; Yamamoto H; Nakashima T; Nishijima T; Satoh M; Hatanaka Y; Shiratsuchi H; Yasumatsu R; Toh S; Komune S; Oda Y
Hum Pathol; 2016 Apr; 50():51-61. PubMed ID: 26997438
[TBL] [Abstract][Full Text] [Related]
19. Human papillomavirus and oral and oropharyngeal carcinoma: the essentials.
Yakin M; Seo B; Hussaini H; Rich A; Hunter K
Aust Dent J; 2019 Mar; 64(1):11-18. PubMed ID: 30238467
[TBL] [Abstract][Full Text] [Related]
20. Human Papillomavirus Impact on Temporal Treatment Trends in Oropharyngeal Carcinoma: 2010-2016.
Amin N; Thompson J; Goloubeva O; Witek M; Taylor RJ; Wolf JS; Moyer K; Mehra R; Hatten KM
ORL J Otorhinolaryngol Relat Spec; 2022; 84(6):438-446. PubMed ID: 36067748
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
